Risperidone Market Report 2026

Risperidone Market Overview

• Risperidone market size has reached to $7.7 billion in 2025 • Expected to grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.6% • Growth Driver: The Increasing Prevalence Of Mental Health Disorders Driving The Growth Of The Market Due To Heightened Stress Levels And Lifestyle Changes • Market Trend: Innovative Long-Acting Injectable Therapies Enhance Treatment Adherence And Symptom Management In Mental Health Disorders • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Risperidone Market?

Risperidone is an atypical antipsychotic medication used to treat mental health disorders such as schizophrenia, bipolar disorder, and irritability associated with autism. It works by balancing certain neurotransmitters in the brain, particularly dopamine and serotonin, to help improve mood, thought processes, and behavior. The main product types of risperidone are tablets, oral solution, and injectable. Tablets refer to an oral medication form of risperidone, used to manage mental health disorders such as schizophrenia, bipolar disorder, and irritability associated with autism by helping balance certain neurotransmitters in the brain. It is administered across different patient age groups, including pediatric patients, adult patients, and elderly patients. It is used in various therapeutic applications such as schizophrenia, bipolar disorder, autism, and other applications. Distribution takes place through multiple channels, including hospital pharmacies, retail pharmacies, online pharmacies, and clinic pharmacies, serving diverse end users such as hospitals, homecare, specialty clinics, ambulatory surgical centers, and other end users.

What Is The Risperidone Market Growth Forecast?

The risperidone market size is expected to see strong growth in the next few years. It will grow to $11.13 billion in 2030 at a compound annual growth rate (CAGR) of 7.6%. The growth in the forecast period can be attributed to increasing demand for long-acting antipsychotic injections, rising focus on personalized psychiatric care, expansion of community mental health services, growing use of digital mental health monitoring, increasing elderly patient population. Major trends in the forecast period include increasing preference for long-acting injectable formulations, rising use of extended-release tablets, growing focus on patient adherence solutions, expansion of pediatric and geriatric dosage forms, enhanced monitoring of treatment outcomes.

Global Risperidone Market Segmentation

1) By Product Type: Tablets, Oral Solution, Injectable 2) By Patient Age Group: Pediatric Patients, Adult Patients, Elderly Patients 3) By Application: Schizophrenia, Bipolar Disorder, Autism, Other Applications 4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinic Pharmacies 5) By End-Users: Hospitals, Homecare, Specialty Clinics, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Tablets: Standard Release, Extended Release, Orally Disintegrating 2) By Oral Solution: Flavored Solution, Unflavored Solution, Concentrated Solution 3) By Injectable: Long Acting Injection, Short Acting Injection, Depot Injection

What Is The Driver Of The Risperidone Market?

The increasing prevalence of mental health disorders is expected to propel the growth of the risperidone market going forward. Mental health disorders refer to a wide range of conditions that affect a person's mood, thinking, and behavior, causing significant distress or impairment in daily functioning. The increasing prevalence of mental health disorders is due to heightened stress levels and modern lifestyle changes that disrupt emotional balance, sleep patterns, and overall psychological well-being. Risperidone helps manage mental health disorders by balancing neurotransmitters in the brain, reducing symptoms such as agitation, hallucinations, and mood swings, and supporting overall emotional stability. For instance, in March 2023, according to the Alzheimer's Association, a US-based nonprofit voluntary health organization, in 2023, approximately 6.7 million Americans aged 65 and older are living with Alzheimer's dementia, and this number is projected to rise to 13.8 million by 2060.Therefore, increasing prevalence of mental health disorders is drives to growth of the risperidone industry.

Key Players In The Global Risperidone Market

Major companies operating in the risperidone market are Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Sun Pharmaceutical Industries Ltd., Apotex Inc., Cipla Limited., Dr. Reddy’s Laboratories Ltd., Hikma Pharmaceuticals PLC, Zydus Cadila Healthcare Ltd, Alkem Laboratories Ltd., Amneal Pharmaceuticals LLC, Natco Pharma Limited., Strides Pharma Science Limited., RPG Life Sciences Limited., Jubilant Cadista Pharmaceuticals Inc., ICROM S.p.A., Accord Healthcare Ltd., Ambica Pharma Machines Pvt. Ltd., Gonane Pharma Private Limited., Janssen Pharmaceuticals, LGM Pharma

Global Risperidone Market Trends and Insights

Major companies operating in the risperidone market are focusing on developing innovative solutions, such as long-acting injectable formulations, to improve patient adherence and treatment outcomes. Long-acting injectable formulations are specially designed medications that release risperidone gradually over time, allowing for less frequent dosing while maintaining consistent therapeutic effects. For instance, in January 2023, Luye Pharma Group Ltd., a China-based pharmaceutical company, received approval from the U.S. Food and Drug Administration (FDA) for Rykindo (risperidone), an extended-release injectable formulation designed for the treatment of schizophrenia in adults, as well as for use as monotherapy or adjunctive therapy with lithium or valproate for the maintenance treatment of bipolar I disorder in adults. This biweekly intramuscular injection of risperidone is developed using Luye Pharma’s advanced microsphere technology, enabling long-acting, sustained-release delivery to maintain symptom control in schizophrenia and bipolar I disorder. The formulation offers a rapid onset of action for quick symptom relief and allows for fast clearance after discontinuation, giving physicians greater flexibility to adjust treatment plans according to patient needs.

What Are Latest Mergers And Acquisitions In The Risperidone Market?

In January 2025, Lyndra Therapeutics Inc., a US-based clinical-stage biopharmaceutical company, partnered with Thermo Fisher Scientific to support clinical research and commercial manufacturing of its long-acting oral therapies. This partnership aims to transform how patients take medicine by providing the capabilities and scale to bring innovative long-acting oral therapies, such as weekly oral risperidone, to broad markets through reliable, scalable manufacturing and clinical trial support. Thermo Fisher Scientific Inc. is a US-based scientific and clinical research company involved in the manufacturing of risperidone.

Regional Insights

North America was the largest region in the risperidone market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Risperidone Market?

The risperidone market consists of sales of orally disintegrating tablets, oral syrups, injectable long-acting formulations, combination formulations, and extended-release tablets. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Risperidone Market Report 2026?

The risperidone market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the risperidone industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.